US Food and Drug Administration has observed "increased risk" of a uncommon neurological disorder.
Washington, United States:
The US Food and Drug Administration connected Monday updated its informing labels for the Johnson & Johnson Covid-19 vaccine to see accusation astir an observed "increased risk" of a uncommon neurological disorder.
Based connected investigation of a national vaccine information monitoring system, officials person identified 100 preliminary reports of Guillain-Barre Syndrome aft astir 12.5 cardinal doses administered, radical acquainted with the substance said.
Of these reports, 95 of them were superior and required hospitalization. There was 1 reported death.